Memorial Sloan Kettering Cancer Center

A new cancer drug called dostarlimab is giving hope for beating rectal and possibly other forms of cancer after a trial resulted in the disappearance of tumors in all fourteen patients. Researchers in the field of colorectal cancer are hailing...